Bausch Health (Germany) Market Value
BVF Stock | EUR 7.63 0.20 2.69% |
Symbol | Bausch |
Bausch Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bausch Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bausch Health.
10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Bausch Health on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Bausch Health Companies or generate 0.0% return on investment in Bausch Health over 30 days. Bausch Health is related to or competes with Eisai Co, Shionogi, Superior Plus, Origin Agritech, Identiv, INTUITIVE SURGICAL, and Intel. Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the... More
Bausch Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bausch Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bausch Health Companies upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.9 | |||
Information Ratio | 0.155 | |||
Maximum Drawdown | 16.12 | |||
Value At Risk | (2.60) | |||
Potential Upside | 6.87 |
Bausch Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bausch Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bausch Health's standard deviation. In reality, there are many statistical measures that can use Bausch Health historical prices to predict the future Bausch Health's volatility.Risk Adjusted Performance | 0.1615 | |||
Jensen Alpha | 0.4631 | |||
Total Risk Alpha | 0.0924 | |||
Sortino Ratio | 0.241 | |||
Treynor Ratio | 0.6122 |
Bausch Health Companies Backtested Returns
Bausch Health appears to be somewhat reliable, given 3 months investment horizon. Bausch Health Companies secures Sharpe Ratio (or Efficiency) of 0.21, which signifies that the company had a 0.21% return per unit of risk over the last 3 months. By analyzing Bausch Health's technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please makes use of Bausch Health's Risk Adjusted Performance of 0.1615, downside deviation of 1.9, and Mean Deviation of 2.06 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bausch Health holds a performance score of 16. The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. Bausch Health returns are very sensitive to returns on the market. As the market goes up or down, Bausch Health is expected to follow. Please check Bausch Health's treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to make a quick decision on whether Bausch Health's price patterns will revert.
Auto-correlation | -0.61 |
Very good reverse predictability
Bausch Health Companies has very good reverse predictability. Overlapping area represents the amount of predictability between Bausch Health time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bausch Health Companies price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Bausch Health price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.61 | |
Spearman Rank Test | 0.31 | |
Residual Average | 0.0 | |
Price Variance | 0.03 |
Bausch Health Companies lagged returns against current returns
Autocorrelation, which is Bausch Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bausch Health's stock expected returns. We can calculate the autocorrelation of Bausch Health returns to help us make a trade decision. For example, suppose you find that Bausch Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Bausch Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bausch Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bausch Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bausch Health stock over time.
Current vs Lagged Prices |
Timeline |
Bausch Health Lagged Returns
When evaluating Bausch Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bausch Health stock have on its future price. Bausch Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bausch Health autocorrelation shows the relationship between Bausch Health stock current value and its past values and can show if there is a momentum factor associated with investing in Bausch Health Companies.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Bausch Stock
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out Bausch Health Correlation, Bausch Health Volatility and Bausch Health Alpha and Beta module to complement your research on Bausch Health. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Bausch Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.